Data compiled by Redley Lamar · ChainSifter Intelligence
3Suppliers
2Customers
2Debt Items
11Related Chains
Source-Backed Evidence Depth
Jasper Therapeutics, Inc. (JSPR) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
8Total relationships
1Distinct source URLs
6High confidence
0.824Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Jasper Therapeutics, Inc. Suppliers
Ticker
Name
Confidence
Evidence
STANFORD
STANFORD
90%
Stanford transferred to the Company certain know-how and patents related to briquilimab
CIRM
CIRM
80%
The Company has received an aggregate of $ 2.3 million from CIRM through March 31, 2026
Reciprocal relationship from SEPN graph: Reciprocal relationship from JSPR graph: Reciprocal relationship from SEPN graph: Reciprocal relationship from JSPR graph: Reciprocal relationship from SEPN g…
Jasper Therapeutics, Inc. Customers
Ticker
Name
Confidence
Evidence
LONZA-SALES-AG
LONZA-SALES-AG
85%
ractices (“cGMP”) regulations for use in our clinical trials. The manufacture of pharmaceuticals is subject to extensive cGMP regulations, which impose various procedural and documentation requiremen…
USA-LLC
USA-LLC
62%
l research to obtain regulatory approval is costly and time-consuming. The actual probability of success for our product candidates may be affected by a variety of factors, including the safety and e…
Jasper Therapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
JSPR-DEBT-10464
Warrants outstanding: 0.0001
90%
xbrl warrant detail from xbrl 2025-12-31.
JSPR-DEBT
Debt stack $757,000
90%
Market cache reports total debt of $757,000.
Jasper Therapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Jasper Therapeutics, Inc..
Jasper Therapeutics, Inc. Ownership
Holder
Name
Confidence
Evidence
JSPR-OWNER-MORGAN-STANLEY
MORGAN STANLEY
90%
13F overlay lists MORGAN STANLEY as top holder; 65 tracked holders.
Jasper Therapeutics, Inc. Extended Supply Chain Network